'''Chemotherapy drugs''' are natural, semisynthetic or synthetic substances with selective inhibitory effects against
biological pathogenic agents, microorganisms to humans and animals  and for atypical cells ( cancer ).
The majority of chemotherapeutic drugs can be divided into [[antifungal agent]]s, antiluetic, [[anti-protozoal]], antituberculotic, anti-leprosy, antihelminitics, [[antiviral]], [[cytostatic]] and other agents.

A fundamental philosophy of [[oncological]] [[combination chemotherapy]] is that different [[chemotherapy]] drugs work through different cytotoxic mechanisms, and that the results of using multiple drugs will be synergistic to some extent.
Because they have different dose-limiting adverse effects, they can be given together at full doses in '''chemotherapy regimens'''.<ref>Mayer, RJ, Targeted therapy for advanced colorectal cancer -- more is not always better, N Engl J Med. 2009;360:623 which is a [possibly critical and not peer reviewed] comment to [http://www.ncbi.nlm.nih.gov/pubmed/19196673 Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.]</ref>

The first successful combination chemotherapy was [[MOPP (medicine)|MOPP]] introduced in 1963 for lymphomas.

The term "induction regimen" refers to a chemotherapy regimen which is used for the initial treatment of a disease. A "maintenance regimen" refers to the ongoing use of chemotherapy that is used to reduce the chances of a cancer recurring or to prevent an existing cancer from continuing to progress.<ref>[http://www.cancer.net/all-about-cancer/cancernet-feature-articles/treatments-tests-and-procedures/explaining-maintenance-therapy Cancer.net - Explaining Maintenance Therapy]</ref>

Chemotherapy regimens are often identified by acronyms, identifying the agents used in the drug combination. However, the letters used are not consistent across regimens, and in some cases - for example, "BEACOPP" - the same letter combination is used to represent two different treatments.<ref>[http://hemonc.org/wiki/Hodgkin_lymphoma BEACOPP chemotherapy regimen]</ref>

There is no widely accepted naming convention or standard for the nomenclature of chemotherapy regimens. For example, either [[generic drug|generic]] or [[brand name]]s may be used for acronyms. This page merely lists commonly used conventions.

==Common chemotherapy acronyms==

{| class="wikitable"
! Name !! Components !! Example of uses, and other notes
|-
| '''[[ABVD]]'''
| Adriamycin ([[doxorubicin]]), [[bleomycin]], [[vinblastine]], [[dacarbazine]]
| [[Hodgkin's lymphoma]]
|-
| '''AC'''
| Adriamycin ([[doxorubicin]]), [[cyclophosphamide]]
| [[Breast cancer]]
|-
| '''[[BEACOPP]]'''
| [[Bleomycin]], [[etoposide]], Adriamycin ([[doxorubicin]]), [[cyclophosphamide]], Oncovin ([[vincristine]]), [[procarbazine]], [[prednisone]]
| [[Hodgkin's lymphoma]]
|-
| '''BEP'''
| [[Bleomycin]], [[etoposide]], platinum agent ([[cisplatin|cisplatin (Platinol)]])
| [[Testicular cancer]], [[germ cell tumor]]s
|-
| '''CA'''
| [[Cyclophosphamide]], Adriamycin ([[doxorubicin]]) (same as AC)
| [[Breast cancer]]
|-
| '''CAF'''
| [[Cyclophosphamide]], Adriamycin ([[doxorubicin]]), [[fluorouracil]] (5-FU)
| [[Breast cancer]]
|-
| '''CAV'''
| [[Cyclophosphamide]], Adriamycin ([[doxorubicin]]), [[vincristine]]
| [[Lung cancer]]
|-
| '''[[CBV (chemotherapy)|CBV]]'''
| [[Cyclophosphamide]], [[BCNU|BCNU (carmustine)]], VP-16 ([[etoposide]])
| [[Lymphoma]]
|-
| '''ChlVPP/EVA'''
| [[Chlorambucil]], vincristine ([[Oncovin]]), [[procarbazine]], [[prednisone]], [[etoposide]], [[vinblastine]], Adriamycin ([[doxorubicin]])
| [[Hodgkin's lymphoma]]
|-
| '''[[CHOP]]'''
| [[Cyclophosphamide]], hydroxydaunorubicin ([[doxorubicin]]), vincristine ([[Oncovin]]), [[prednisone]]
| [[Non-Hodgkin lymphoma]]
|-
| '''[[CHOP-R]]''' or '''R-CHOP'''
| CHOP + [[rituximab]]
| [[B cell]] [[non-Hodgkin lymphoma]]
|-
| '''[[CHOP|COP]]''' or '''[[CHOP|CVP]]'''
| [[Cyclophosphamide]], Oncovin ([[vincristine]]), [[prednisone]]
| [[Non-Hodgkin lymphoma]] in patients with history of [[cardiovascular disease]]
|-
| '''[[Cyclophosphamide, methotrexate and fluorouracil|CMF]]'''
| [[Cyclophosphamide]], [[methotrexate]], [[fluorouracil]] (5-FU)
| [[Breast cancer]]
|-
| '''[[COPP (chemotherapy)|COPP]]'''
| [[Cyclophosphamide]], Oncovin ([[vincristine]]), [[procarbazine]], [[prednisone]]
| [[Non-Hodgkin lymphoma]]
|-
| '''[[HyperCVAD|CVAD / HyperCVAD]]'''
| [[Cyclophosphamide]], [[Vincristine]], Adriamycin ([[doxorubicin]]), [[dexamethasone]]
| Aggressive [[non-Hodgkin lymphoma]], [[lymphoblastic lymphoma]], some forms of [[leukemia]]
|-
| [[DT-PACE]]
| [[Dexamethasone]], [[Thalidomide]], [[Cisplatin]] or [[Platinol]], [[Adriamycin]] or [[doxorubicin]], [[Cyclophosphamide]], [[Etoposide]]
| [[Multiple myeloma]]
|-
| '''EC'''
| [[Epirubicin]], [[cyclophosphamide]]
| [[Breast cancer]]
|-
| '''ECF'''
| [[Epirubicin]], [[cisplatin]], [[fluorouracil]] (5-FU)
| [[Gastric cancer]] and [[oesophageal cancer]]
|-
| '''EP'''
| [[Etoposide]], platinum agent ([[cisplatin|cisplatin (Platinol)]])
| [[Testicular cancer]], [[germ cell tumor]]s
|-
| '''EPOCH'''
| [[Etoposide]], [[prednisone]], [[Oncovin]], [[cyclophosphamide]], and [[hydroxydaunorubicin]]
| [[Lymphomas]]
|-
| '''FEC'''
| [[Fluorouracil]] (5-FU), [[epirubicin]], [[cyclophosphamide]]
| [[Breast cancer]]
|-
| '''FL''' (Also known as Mayo)
| [[Fluorouracil]] (5-FU), leucovorin ([[folinic acid]])
| [[Colorectal cancer]]
|-
| '''[[FOLFOX]]'''
| [[Fluorouracil]] (5-FU), leucovorin ([[folinic acid]]), [[oxaliplatin]]
| [[Colorectal cancer]]
|-
| '''[[FOLFIRI]]'''
| [[Fluorouracil]] (5-FU), leucovorin ([[folinic acid]]), [[irinotecan]]
| [[Colorectal cancer]]
|-
| '''[[ICE chemotherapy regimen|ICE]]'''
| [[ifosfamide]], [[carboplatin]], [[etoposide]] (VP-16)
| Aggressive [[lymphomas]], progressive [[neuroblastoma]]
|-
| '''ICE-R'''
| [[ICE chemotherapy regimen|ICE]] + [[rituximab]]
| High-risk progressive or recurrent [[lymphomas]]
|-
| '''m-BACOD'''
| [[Methotrexate]], [[bleomycin]], Adriamycin ([[doxorubicin]]), [[cyclophosphamide]], Oncovin ([[vincristine]]), [[dexamethasone]]
| [[Non-Hodgkin lymphoma]]
|-
| '''MACOP-B'''
| [[Methotrexate]], leucovorin ([[folinic acid]]), Adriamycin ([[doxorubicin]]), [[cyclophosphamide]], Oncovin ([[vincristine]]), [[prednisone]], [[bleomycin]]
| [[Non-Hodgkin lymphoma]]
|-
| '''[[MOPP (medicine)|MOPP]]'''
| [[Mechlorethamine]], Oncovin ([[vincristine]]), [[procarbazine]], [[prednisone]]
| [[Hodgkin's lymphoma]]
|- 
|'''MVAC'''
| [[methotrexate]], [[vinblastine]], [[adriamycin]], [[cisplatin]]
| Advanced [[bladder cancer]]<ref>[http://www.cancernetwork.com/bladder-cancer/content/article/10165/71963 MVAC Still the ‘Best Treatment’ for Advanced Bladder Cancer Patients. 1999]</ref>
|-
| '''PCV'''
| [[Procarbazine]], CCNU ([[lomustine]]), [[vincristine]] 
| [[Brain tumors]]
|-
| '''POMP'''
| 6-[[mercaptopurine]] (Purinethol), [[vincristine]] (Oncovin), [[methotrexate]], and [[prednisone]]
| acute adult [[leukemia]]<ref>[http://onlinelibrary.wiley.com/doi/10.1002/1097-0142%28197307%2932:1%3C69::AID-CNCR2820320109%3E3.0.CO;2-0/abstract POMP combination chemotherapy of adult acute leukemia.]</ref>
|-
| '''ProMACE-MOPP'''
| [[Methotrexate]], Adriamycin ([[doxorubicin]]), [[cyclophosphamide]], [[etoposide]] + [[MOPP (medicine)|MOPP]]
| [[Non-Hodgkin lymphoma]]
|-
| '''ProMACE-CytaBOM'''
| [[Prednisone]], [[doxorubicin]] ([[adriamycin]]), [[cyclophosphamide]], [[etoposide]], [[cytarabine]], [[bleomycin]], Oncovin ([[vincristine]]), [[methotrexate]], [[leucovorin]]
| [[Non-Hodgkin lymphoma]]
|-
| '''R-FCM'''
| [[Rituximab]], [[fludarabine]], [[cyclophosphamide]], [[mitoxantrone]]
| [[B cell]] non-Hodgkin lymphoma
|-
| '''[[Stanford V]]'''
| [[Doxorubicin]], [[mechlorethamine]], [[bleomycin]], [[vinblastine]], [[vincristine]], [[etoposide]], [[prednisone]]
| [[Hodgkin lymphoma]]
|-
| '''Thal/Dex'''
| [[Thalidomide]], [[dexamethasone]]
| [[Multiple myeloma]]
|-
| '''TIP'''
| [[Paclitaxel]], [[ifosfamide]], platinum agent [[cisplatin|cisplatin (Platinol)]]
| [[Testicular cancer]], [[germ cell tumor]]s in salvage therapy
|-
| '''{{visible anchor|EE-4A}}'''
| [[Vincristine]], [[Actinomycin]]<ref name=nci/>
| [[Wilms' tumor]]<ref name=nci>[http://www.cancer.gov/cancertopics/pdq/treatment/wilms/HealthProfessional/Page5 Treatment of Wilms Tumor] at [[National Cancer Institute]]. Last Modified: 03/29/2012</ref>
|-
| '''{{visible anchor|DD-4A}}'''
| [[Vincristine]], [[Actinomycin]], [[Doxorubicin]]<ref name=nci/>
| [[Wilms' tumor]]<ref name=nci/>
|-
| '''VAC'''
| [[Vincristine]], [[Actinomycin]], [[Cyclophosphamide]]
| [[Rhabdomyosarcoma]]
|-
| '''VAD'''
| [[Vincristine]], Adriamycin ([[doxorubicin]]), [[dexamethasone]]
| [[Multiple myeloma]]
|-
| '''[[VAMP Regimen|VAMP]]'''
| One of 3 combinations of [[Vincristine]] and others
| [[Hodgkin's lymphoma]], [[leukemia]], [[multiple myeloma]]
|-
| '''{{visible anchor|Regimen I}}'''
| [[Vincristine]], Adriamycin ([[doxorubicin]]), [[etoposide]], [[cyclophosphamide]]
| [[Wilms' tumor]]<ref name=nci/>
|-
| '''VAPEC-B'''
| [[Vincristine]], Adriamycin ([[doxorubicin]]), [[prednisone]], [[etoposide]], [[cyclophosphamide]], [[bleomycin]]
| [[Hodgkin's lymphoma]]
|-
| '''VIP'''
| [[Vinblastin]], [[ifosfamide]], platinum agent [[cisplatin|cisplatin (Platinol)]]
| [[Testicular cancer]], [[germ cell tumor]]s
|}

==See also==
* [[Chemotherapy]], eg. for other non-combination therapies
* [[National Comprehensive Cancer Network|National Comprehensive Cancer Network Treatment Guidelines]]

==References==
{{Reflist}}

==External links==
* [http://hemonc.org/wiki/Main_Page Chemotherapy regimens and references]
* [http://chemocare.com/bio/ Chemotherapy side effects]
* [http://www.christie.nhs.uk/patients/booklets/chemo_index.aspx Christie Hospital Chemotherapy Patient Information Sheets]
* [http://dpd-deficiency.com Site dedicated exclusively to DPD Deficiency and Fluorouracil (5-FU) Toxicity related issues - dpd-deficiency.com]

{{Chemotherapeutic Agents}}

[[Category:Chemotherapy regimens]]